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Abstract: Traumatic brain injury (TBI) occurs when a sudden trauma causes damage to the brain.
TBI can result when the head suddenly and violently impacts an object or when an object pierces
the skull and enters brain tissue. Secondary injuries after traumatic brain injury (TBI) can lead
to impairments on cerebral oxygenation and autoregulation. Considering that secondary brain
injuries often take place within the first hours after the trauma, noninvasive monitoring might be
helpful in providing early information on the brain’s condition. Near-infrared spectroscopy (NIRS)
is an emerging noninvasive monitoring modality based on chromophore absorption of infrared
light with the capability of monitoring perfusion of the brain. This review investigates the main
applications of NIRS in TBI monitoring and presents a thorough revision of those applications on
oxygenation and autoregulation monitoring. Databases such as PubMed, EMBASE, Web of Science,
Scopus, and Cochrane library were utilized in identifying 72 publications spanning between 1977
and 2020 which were directly relevant to this review. The majority of the evidence found used
NIRS for diagnosis applications, especially in oxygenation and autoregulation monitoring (59%).
It was not surprising that nearly all the patients were male adults with severe trauma who were
monitored mostly with continue wave NIRS or spatially resolved spectroscopy NIRS and an invasive
monitoring device. In general, a high proportion of the assessed papers have concluded that NIRS
could be a potential noninvasive technique for assessing TBI, despite the various methodological and
technological limitations of NIRS.
Keywords: near infrared spectroscopy; traumatic brain injury; cerebral oxygenation; cerebral autoregulation
1. Introduction
Traumatic brain injury (TBI) is defined as an alteration in brain function or pathology
caused by an external force. Based on psychological and anatomical features evaluated
by scales such as the Glasgow Coma Scale, TBI can be categorized into mild, moderate,
or severe [1]. It is estimated that there are 50 million new cases of TBI every year world-
wide [2]. The incidence rate of TBI has increased 3.6% in the last 30 years, and it has
been predicted that it will remain the most important cause of disability from neurological
disease until 2030, even two to three times higher than the contribution from Alzheimer’s
disease [2]. According to the European Union statistics, there are 1.5 million hospital
admissions due to TBI per year, with a mortality rate between 30% and 40%, with one
person dying every 10 min because of head trauma [2]. The treatment costs associated
with TBI are estimated to be around $400 billion annually, resulting in approximately
$55,000 per patient [3]. These financial values do not take into account the rehabilitation
cost (10% higher than hospitalisation costs) and all the other indirect expenses such as
productivity loss, disability, and reduction of quality of life [4].
The most common mechanism of injuries which can cause TBI are hits, falls, violence,
concussion, shaken baby syndrome, blast, and whiplash [5–11]. Patients may suffer un-
avoidable injuries such as fractures leading to deformation or destruction of brain tissue,
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whereas avoidable secondary injuries such as swelling and hematomas, which compress
vital brain structures and displace the brain midline, may also take place. In many cases,
those secondary injuries are followed by obstructions of cerebrospinal fluid (CSF) paths—
generating hydrocephalus—as well as blockage of arteries which may result in ischemia.
These damages can also alter autoregulation capacity, increase intracranial pressure, and re-
duce blood pressure to the brain, which, in turn, can all lead to brain hypoxia [12,13].
Considering that secondary brain injuries often take place within the first hours after
a trauma, noninvasive monitoring might be helpful in providing early information on the
brain’s condition [14]. Unfortunately, continuous and noninvasive monitoring of brain’s
hemodynamics is scarcely available, even for severe cases of TBI [15]. Current clinical
practices primarily utilize invasive methods for assessing TBI. Such methods include
probes and/or catheters to measure intracranial pressure (ICP), brain temperature (BT),
brain oxygen tension (PbtO2), neurochemistry via microdialysis (MD), cerebral blood
flow (CBF), and jugular oxygen saturation (SjvO2) [16]. The aforementioned approaches
introduce additional risks and require neurosurgical expertise, thus potentially causing
delays in providing useful clinical information [17,18]. Furthermore, studies have shown
that an initial phase of cerebral hypoperfusion, which is not assessed and treated on
time during the early post-traumatic period, can contribute to increased mortality and
worsened neurological outcome in 60–80% of TBI patients [15,18]. Imaging techniques such
as computerized tomography (CT) and magnetic resonance imaging (MRI) could provide
a solution to the above challenges, but such techniques cannot be used for continuous
monitoring of TBI at the bed site [19].
In consequence, an ideal neuromonitoring system should be continuous, affordable,
noninvasive, and suitable for bedside use or in field monitoring (i.e., ambulances) [20].
Since 1977, when near-infrared spectroscopy (NIRS) was first described for monitoring
cerebral perfusion and brain oxygenation [21], clinical interest on this optical technology
has increased. Near-infrared (NIR) represents wavelengths within the range of 700 nm
and 1000 nm, where the absorption contribution of chromophores such as oxygenated
and deoxygenated hemoglobin is maximized, while the absorption contribution of other
compounds such as water molecules is minimized. NIR light can penetrate bony structures
and several millimetres into cerebral tissue, where according to Beer–Lambert law, light
absorption is directly proportional to the concentration of chromophores. The reflected light
attenuation represents information regarding regional cerebral oxygen saturation (rSO2)
and the balance between oxygen delivery and oxygen consumption, making NIRS a very
sensitive technology to changes in cerebral oxygenation [22]. Based on the aforementioned,
NIRS could potentially address ideal neuromonitoring requirements, detect brain tissue at
risk of secondary injury, and complement or even replace current invasive practices [23,24].
Overall, current evidence suggests that NIRS allows the detection of intracranial bleeding,
the assessment of brain tissue oxygenation and cerebral perfusion. NIRS has also been
applied in the evaluation of cerebral autoregulation and intracellular metabolic state during
the early post-traumatic period. Furthermore, this optical technique can be also applied
during neurorehabilitation [23].
This review aims to rigorously investigate the utilisation of NIRS in TBI and provide a
synthesis of the available evidence of the association between continuous NIRS-based mea-
surements and commonly monitored neurophysiological parameters, such as oxygenation
and cerebral autoregulation. So far, no review is known by the authors that synthesized
multiple clinical applications of NIRS in TBI nor considered the different types of NIRS
technologies in relation to TBI physiology. This synthesis highlights several factors that are
important for future research, including literature trends, the comparison between NIRS
measurements and validated neuromonitoring parameters, and their relationship with
brain physiological changes following trauma.
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2. Materials and Methods
PubMed, EMBASE, Web of Science, Scopus, and Cochrane library databases were
used to search for literature that investigates the use of NIRS in TBI monitoring. As this
review aims to describe every technological advancement of NIRS in TBI monitoring,
the studies were included without time restriction. The search terms used were a com-
bination of the terms “near-infrared spectroscopy,” “NIRS,” “TBI,” and “traumatic brain
injury”, assessed on the title, abstract, and keywords. Databases search yielded 139 results,
seven of which were review papers. The references from these reviews were examined,
resulting 68 publications of interest for the current research. In total, the search resulted
207 papers; 90 of which were duplicates and were removed. From the remaining 117 papers,
72 met the inclusion criteria and were included in the analysis. Papers were included in
the review if they used NIRS in TBI monitoring and were written in English. Review
articles, nonoriginal, nonindependent documents and animal studies were excluded (see
Figure 1). It is recognized that a potential limitation of this review is the possibility of
search engine bias. Only articles that were tagged with these terms were included and
therefore, qualifying articles may have been missed in the search.
Figure 1. Flowchart of the methodology used to include 72 out of 207 studies published until
July 2020.
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Demographics, study characteristics, and outcome measures were extracted from
the selected articles and compiled in an electronic database. Data fields included biblio-
graphic data, sample size, patients’ characteristics, NIRS application, outcome measures,
limitations, and conclusions. Papers were classified into five categories according to NIRS
applications: diagnosis, prognosis, treatment, correlation, and comparison between NIRS
technologies capacities. The diagnosis group was also subdivided into subgroups relating
to the outcome measured: oxygenation, autoregulation, hematomas, and neurorehabilita-
tion. Oxygenation, autoregulation, and hematomas monitoring are relevant during TBI’s
“golden hour”, while neurorehabilitation monitoring usually takes place some months
after injury. Moreover, oxygenation and autoregulation monitoring utilize similar NIRS
sensors and algorithms, while hematomas monitoring involves multiple NIRS sensors
and a specific algorithm for hematoma detection. Thus, this review examined the main
applications of NIRS for TBI monitoring, and it presents a thorough revision of those
applications on oxygenation and autoregulation for TBI patients’ diagnosis.
3. Results
3.1. Search Results
The literature search returned 72 scientific publications that met the inclusion criteria,
all of which were included in the general analysis of NIRS application in TBI monitoring.
To gain a better understanding of the trends and geographical distribution of the included
papers, the data were analyzed by year and country as well as by NIRS applications and
outcome measure. The distribution of the published literature by country indicates that the
United States of America (USA) provided the most significant contribution in the field with
28 publications, followed by the United Kingdom (UK) with 14 publications, as shown
in Figure 2. With the USA as the front runner in terms of volume of research, it is recom-
mended that other countries continue or increase their investigations in this field, given the
substantial impact of TBI on mortality and disability rates [7]. This recommendation is
also justified by the fact that 80% of the incident cases per year are from low and middle
income countries [2], while most of the scientific contribution is from high income countries.
As this research intended to describe the characteristics and advantages of NIRS in TBI
monitoring for its future use across various populations, ideally NIRS should be assessed
across individuals of various ethnic backgrounds from around the world.
Figure 2. Global distribution of scientific articles that discussed the use of near-infrared spectroscopy (NIRS) technology in
traumatic brain injury (TBI) monitoring until July 2020. The number of publications per country is indicated by the intensity
of the color, with darker colors representing a higher number of articles than lighter colors.
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Until July 2020, the number of papers published that have used NIRS in TBI monitor-
ing experienced a downward trend. The largest amount of publications on the topic were in
2014. However, since 2003, other applications in addition to diagnosis have been reported
(Figure 3). In total, 46 (64%) publications were found that used NIRS as a diagnostic
tool in TBI monitoring. Figure 4 shows the percentage of diagnosis papers per subgroup.
The outcome of neurorehabilitation is mainly related to prefrontal cortex features. All the
prognosis papers (n = 18) assessed patients’ neurorehabilitation using NIRS, however,
there was just one diagnosis publication where NIRS was used to identify regions within
the prefrontal cortex that contributed to distinguishing between TBI and healthy sub-
jects [25]. Likewise, 18 studies were included that explored NIRS accuracy for hematoma
detection after trauma. Hematoma detection using NIRS technology is based on differential
light absorption of the left versus the right side of the brain [26–29]. Brain absorption is
symmetrical under normal circumstances and when extravascular blood is present due to a
hematoma, the reflected component of light is significantly lower [26–29]. The absorption
differential can be detected via NIRS units placed over symmetrical locations on both sites
of the head [26–29]. Neurorehabilitation and hematomas monitoring are relevant outcomes
in TBI monitoring, however, the current research presents a thorough revision of NIRS
applications on oxygenation and autoregulation due to the relevance of those outcomes in
TBI’s “golden hour” and their technological similarities [30,31].
Figure 3. Number of publications per year associating TBI with the various types of NIRS applications.
Figure 4. Percentage of diagnosis papers per subgroup according to the outcome measured:
oxygenation, autoregulation, hematomas, and neurorehabilitation monitoring.
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3.2. Physical and Technological Description of NIRS
Red blood cells (RBC) contain a protein with high gas-bounding capacity called
hemoglobin, which allows oxygen transport [32,33]. When gas exchange takes place
in the lungs, each hemoglobin binds to four oxygen molecules. Then, RBCs carry this
oxyhemoglobin (HbO2) through the arteries to the tissues, where oxygen is delivered
through a process known as oxygen perfusion. Although some oxygen can still be bound
to hemoglobin, when it has released most of the oxygen molecules (deoxyhemoglobin
HHb), it can collect part of the CO2 discharged by the tissues. Finally, CO2 is transported
in venous blood and is released into the lungs, where it is expelled by exhalation [32,33].
Arterial blood, rich in O2, has a bright red color, while venous blood color is dark red
due to its poor O2 content. This physical property is used by near-infrared spectroscopy
(NIRS) as explained below [32]. Near-infrared (NIR) light is absorbed to different de-
grees by the chromophores, oxyhemoglobin, deoxyhemoglobin, and cytochrome-c-oxidase,
at wavelengths near 700–1300 nm [34]. Within this range, light has low absorption and
high scattering properties, causing the light to go deeper into the tissue, therefore enabling
real-time noninvasive monitoring of brain tissue oxygen saturation [21]. NIRS uses the
different absorption properties of these chromophores to quantify their concentrations
in tissues [35]. NIRS bases its principles on the Beer–Lambert law, which correlates the
absorption of light passing through the tissue to the absorption coefficient (µa = ε·c) and




= ε× c × l (1)
where A is light attenuation, also known as optical density, I is transmitted light intensity,
I0 is incidence light intensity, ε is the tissue’s extinction coefficient (Figure 5a), c is chro-
mophore concentration and l is distance travelled by light in the tissue on the assumption
that light only undergoes absorption [37].
Figure 5. (a) Absorption coefficient spectra of oxyhemoglobin (HbO2) and deoxyhemoglobin (HHb). (b) The probabilistic
trajectory of photons from the source to a detector of incident near-infrared light is described as a “banana shape” [38].
Figure modified from [39].
When the tissue contains multiple chromophores, total light attenuation (A) can
be defined as the linear sum of the contribution of each chromophore’s concentration.
Thus, the tissue is illuminated with as many wavelengths as chromophores are being
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assessed. The result is a system of equations with the specific purpose of calculating the
concentrations of HbO2 and HHb by NIRS [40]:
Aλ1 =
(





εHbO2λ2 × [HbO2] + εHHbλ2 × [HHb]
)
× l (3)
where λ1 and λ2 are two different wavelengths. However, this assumption is not completely
valid in tissues, where near-infrared light attenuation (A) is highly dominated by scattering
(roughly 80% scattering vs. 20% absorption) [37]. Scattering in tissue causes an increase
of the pathlength travelled by light, as well as the loss of scattered light because it cannot
reach the detector (Figure 5b). The modified Beer–Lambert law considers the effects of
scattering in tissues [37,41], where the distance travelled by light (l) is replaced by the
product of the differential path factor (DPF) and the separation distance (d) between the
sensor’s emitter and detector [41], as is shown in Equation (4). The DPF is the increase on
the light’s pathlength due to scattering, where this coefficient depends on the wavelength,
tissue type, and emitter detector distance [38]. Finally, the modified Beer–Lambert law
adds the factor G, or scattering coefficient (µs), to the equation, which represents both the
nature and the geometry of the tissue [41].
Aλ = (ε1λ × [C1] + ε2λ × [C2] + . . . εnλ × [Cn])× d × DPF + G (4)
Although increasing emitter–detector separation distance increases penetration depth,
it also causes a decrease in overall signal quality due to high absorption [42]. Thus, emitter–
detector separation distances between 2.5 and 5.0 cm is the range suggested to obtain good
quality NIRS measurements [35,38].
Two of the major parameters of interest in perfusion analysis are tissue oxygen satu-
ration index (rSO2) and tissue oxygenation index (TOI). Both represent the percentage of
oxygenated hemoglobin in the sample volume [43]. Near-infrared spectroscopy is used
for the determination of changes in HbO2 and HHb concentrations. From these data,
some commercial NIRS systems derive rSO2 (i.e., INVOS 5100 (Medtronic, MN, USA)).
Other sensors interrogate the change of light attenuation along the detector’s distance to
calculate the relative concentrations of HbO2 and HHb and generate TOI (i.e., NIRO-300
(Hamamatsu Photonics KK, Hamamatsu City, Japan)). Despite the differences of the algo-
rithms, both indices are expressed as percentages of oxygenated hemoglobin relative to




NIRS cannot discriminate between arterial blood, capillaries, and venous blood. In con-
sequence, oxygen saturation measured by NIRS represents a mixed saturation between
arterial and venous blood. This measure is predominantly from venous oxygenation,
as approximately 75% of cerebral blood is venous [45]. The above explains why NIRS mea-
surements are always lower than arterial oxygen saturation measured by pulse oximetry
(SpO2), which assesses only arterial blood by utilizing the arterial pulsatile component of
the signal [37].
3.3. NIRS Measurement Techniques
Four measurement techniques have been developed since NIRS was invented. All of
them aim to quantify HbO2 and HHb concentration by applying different measurement
principles [36], as shown in Figure 6.
In continuous wave NIRS (CW-NIRS), as the name suggests, light of constant intensity
is “injected” into tissue, and then the attenuated light signal is measured at a distance
from the light source (Figure 6a). This technique assumes that HbO2 and HHb are the
only absorbers in tissue. It also assumes that scattering is constant during the entire
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measurement (∆G = 0) and DPF is considered to be between one half and one third of the
actual emitter–detector separation distance. In consequence, the modified Beer–Lambert
law (MBL) is used to calculate the change in chromophores concentrations [35,38,46,47].
However, its major challenge is to remove any superficial layer contamination from the
brain signal, taking into account that the brain is covered by multiple layers which are
perfused by vessels that carry hemoglobin, leading to extracerebral signals that play a
contaminating role on CW-NIRS [48].




Figure 6. Schematic diagram of NIRS detection modes. (a) Continuous wave NIRS (CW-NIRS), (b) 
spatially resolved spectroscopy (SRS), (c) time-resolved spectroscopy (TD-NIRS), and (d) phase 
modulated spectroscopy (PMS). The figure also shows a representation of the photon path in tis-
sues for each technique. S: source, D: detector. (Figure modified from [49]). 
Spatially resolved spectroscopy (SRS) is based on the measurement of light attenua-
tion at several source–detector separations (Error! Reference source not found.b), where 
relative concentrations of HbO2 and HHb can be calculated by solving the diffusion equa-
tion as a function of the photodetectors’ distance [36,41,50,51]. This method enhances the 
contribution of deeper tissues (S-D2 or S-D3) while reducing the contribution of more su-
perficial tissues (S-D1). The latter is the biggest advantage of the SRS design over the MBL 
algorithm, when using CW-NIRS. Time-resolved spectroscopy mode (TD-NIRS), uses 
short light pulses to illuminate the tissue, where the scattered photons take more time to 
(a) (b) 
(c) (d) 
Figure 6. Schematic diagram of NIRS detection modes. (a) Continuous wave NIRS (CW-NIRS), (b) spatially resolved
spectroscopy (SRS), (c) time-resolved spectroscopy (TD-NIRS), and (d) phase modulated spectroscopy (PMS). The figure
also shows a representation of the photon path in tissues for each technique. S: source, D: detector. (Figure modified
from [49]).
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Spatially resolved spectroscopy (SRS) is based on the measurement of light attenua-
tion at several source–detector separations (Figure 6b), where relative concentrations of
HbO2 and HHb can be calculated by solving the diffusion equation as a function of the
photodetectors’ distance [36,41,50,51]. This method enhances the contribution of deeper
tissues (S-D2 or S-D3) while reducing the contribution of more superficial tissues (S-D1).
The latter is the biggest advantage of the SRS design over the MBL algorithm, when us-
ing CW-NIRS. Time-resolved spectroscopy mode (TD-NIRS), uses short light pulses to
illuminate the tissue, where the scattered photons take more time to be detected than the
unscattered photons (Figure 6c). Average photons’ arrival time allows the calculation of the
light pathlength, therefore enabling the calculation of the chromophores’ absolute concen-
trations by solving the diffusion equation [36,41,46,47]. In phase modulated spectroscopy
(PMS), the emitted light is modulated in frequency and intensity, thus, measured atten-
uations and frequency shift are used to estimate the light pathlength and the absorption
and scattering properties of the tissue (Figure 6d). Once these are derived, at least from
two wavelengths, absolute concentrations of HbO2 and HHb can be calculated from the
modified Beer–Lambert law [36,41,46,47].
3.4. Subgroups
The previous sections described the principles of NIRS. Many clinical and research
applications using NIRS in TBI monitoring have been reported in the last 40 years. This sec-
tion provides an overview of its application in oxygenation and autoregulation monitoring
for TBI diagnosis, considering different types of NIRS technologies and TBI’s physiology.
3.4.1. Oxygenation
Physiology of Oxygenation in TBI
The brain is dependent on continuous oxygenated blood supply. Ten seconds of
ischemia leads to unconsciousness, 20 s ceases neuronal activity, and a few minutes of
ischemia lead to irreversible damage [52]. The internal carotid system provides 80% of
cerebral blood, where each side supplies an ipsilateral cerebral hemisphere [52]. Once blood
reaches the capillary bed, oxygen and nutrient delivery are exchanged for disposable
substances such as carbon dioxide (CO2) This deoxygenated blood is drained by two sets of
veins, the superficial and deep veins, which join the cerebral sinuses. Then, deoxygenated
blood reaches the internal jugular vein, which returns blood to the right atrium of the
heart [52,53].
NIRS-derived regional cerebral oxygen saturation (rSO2) is an indirect marker of
cerebral venous oxygenation and has been shown to correlate with jugular bulb venous
saturation (SjO2), see Figure 7 [54]. As it was explained above, deoxygenated blood and the
remaining oxygen flows through the internal jugular veins to return to the heart. Therefore,
the measurement of SjO2 helps establish the balance between cerebral blood flow (CBF)
and metabolic requirement (CMRO2), giving an indication of the use of oxygen by the
brain [55]. Accordingly, when oxygen demand increases, brain extracts a greater amount of
oxygen, resulting in decreased jugular venous oxygen saturation. Conversely, when CBF
exceeds metabolic requirement, venous oxygen saturation is higher [55]. The following
equation explains the physiology behind SjO2 and its dependency on CBF and CMRO2,
assuming constant arterial oxygenation (SaO2) [55,56].
SjO2 = SaO2 − (CMRO2/(1.34[Hb]× CBF)) (6)
After TBI, the coupling between CMRO2 and CBF is lost. Thus, intracranial hyperten-
sion leads to brain hypoperfusion, which is not accompanied by a proportional reduction
in CMRO2. Consequently, SjO2 falls from a normal 60–75% range to values below 55%,
which are associated with a poor outcome. SjO2 might decrease below 50% when at
least 13% of the brain has become ischemic, due to oxygen supply being critically low
for metabolic demand [12,55]. Likewise, when cerebral autoregulation fails because of
trauma, the vasodilatory response increases CBF, leading to cerebral hyperemia with de-
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creased oxygen extraction. Therefore, SjO2 values rise over 75%, representing an unbalance
between CBF and CMRO2 [55]. Likewise, a NIRS-derived rSO2 value less than 60% for
extended periods after TBI is associated with higher mortality, intracranial hypertension,
and impaired cerebral perfusion. Also, rSO2 is moderately accurate at predicting severe
brain hypoxia [54].




Figure 7. NIRS-derived regional tissue oxygen saturation (green probe) analyzes the oxygen con-
centration in cerebral microcirculation, which is predominantly from venous oxygenation. Jugular 
bulb venous saturation (blue probe) analyzes the remaining oxygen concentration that flows from 
the venous sinuses to the internal jugular vein. Both are indirect measurements of how much oxy-
gen is being used by the brain. Brain tissue oxygenation tension (yellow probe) analyzes the dis-
solved oxygen within the cerebral plasma that diffuses across the blood brain barrier (BBB). (Fig-
ure modified from [57,58]). 
Another fundamental pathophysiological consequence after TBI is an imbalance of 
oxygen delivery to neural tissue [59]. Understanding the physiology of brain tissue oxy-
gen tension (PbtO2) is significantly important in this research. PbtO2 reflects the dissolved 
oxygen within the plasma that diffuses across the blood-brain barrier rather than the en-
tire oxygen content or cerebral metabolism [60]. The above, due to PbtO2, is significantly 
related to the product of CBF and arteriovenous oxygen tension difference (Equation (7)), 
which is influenced by the oxygen diffusion gradient [56,60,61]. Equation (7) presents the 
association between PbtO2 and oxygen diffusion or cerebral blood flow, where the con-
version factor 1 mmHg = 0.0031 mL/100 gr can be used to keep Equation (7) dimensionally 
consistent in millimeter of mercury [56]. Thus, PbtO2 is not simply an ischemia biomarker, 
since several variables might modify oxygen diffusion or metabolism, even under normal 
CBF conditions [61]. However, low PbtO2 values can result from low PaO2, local O2 ex-
traction impairment, or decreased cerebral blood flow [60,61]. PbtO  CBF × (PaO − PjO ) (7)
PbtO2 values around 23–35 mmHg are typically found in a healthy state. Values be-
low 20 mmHg are considered abnormal and have been associated with greater evidence 
for cerebral ischemia and energy dysfunction. Some authors suggest treatment when 
PbtO2 is below 15 mmHg [61]. Thresholds for ischemia are not yet clearly defined, but a 
PbtO2 below 8–10 mmHg seems to indicate a high risk of ischemia in patients with sub-
arachnoid hemorrhage. Low values of PbtO2, particularly if they are sustained, are asso-
ciated with poor outcome after traumatic brain injury, and there is some evidence that 
brain tissue oxygen-directed therapy may improve outcome in such patients [45]. 
As it has been explained above, oxygen supply is a key component in secondary cer-
ebral damage, nevertheless, it is also important to consider cellular metabolism failure as 
a possible outcome after trauma. The latter inhibits the use of delivered oxygen and glu-
cose by the mitochondria, hampering adenosine triphosphate (ATP) synthesis. Cyto-
Figure 7. NIRS-derived regional tissue oxygen saturation (green probe) analyzes the oxygen concentration in cerebral
microcirculation, which is predominantly from venous oxygenation. Jugular bulb venous saturation (blue probe) analyzes
the remaining oxygen concentration that flows from the venous sinuses to the internal jugular vein. Both are indirect
measurements of how much oxygen is being used by the brain. Brain tissue oxygenation tension (yellow probe) analyzes
the dissolved oxygen within the cerebral plasma that diffuses across the blood brain barrier (BBB). (Figure modified
from [57,58]).
Another fundamental pathophysiological consequence after TBI is an imbalance
of oxygen delivery to neural tissue [59]. Understanding the physiology of brain tissue
oxygen tension (PbtO2) is significantly important in this research. PbtO2 reflects the
dissolved oxygen within the plasma that diffuses across the blood-brain barrier rather
than the entire oxygen content or cerebral metabolism [60]. The above, due to PbtO2,
is significantly related to the product of CBF and arteriovenous oxygen tension difference
(Equation (7)), which is influenced by the oxygen diffusion gradient [56,60,61]. Equation (7)
presents the association between PbtO2 and oxygen diffusion or cerebral blood flow,
where the conversion factor 1 mmHg = 0.0031 mL/100 gr can be used to keep Equation (7)
dimensionally consistent in millimeter of mercury [56]. Thus, PbtO2 is not simply an
ischemia biomarker, since several variables might modify oxygen diffusion or metabolism,
even under normal CBF conditions [61]. However, low PbtO2 values can result from low
PaO2, local O2 extraction impairment, or decreased cerebral blood flow [60,61].
PbtO2 ≈ CBF × (PaO2 − PjO2) (7)
PbtO2 values around 23–35 mmHg are typically found in a healthy state. Values below
20 mmHg are considered abnormal and have been associated wi h great r evidence for
cerebral ischemia and energy dysfuncti n. Some authors suggest treatment when PbtO2
is below 15 mmHg [61]. T resholds for ischemia are not y t clearly d fined, but a PbtO2
below 8–10 mmHg seems to indicate a igh risk of ischemia in patients with subarachnoid
he orrhage. o values of Pbt , particularly if they are sustaine , are associated with
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poor outcome after traumatic brain injury, and there is some evidence that brain tissue
oxygen-directed therapy may improve outcome in such patients [45].
As it has been explained above, oxygen supply is a key component in secondary
cerebral damage, nevertheless, it is also important to consider cellular metabolism fail-
ure as a possible outcome after trauma. The latter inhibits the use of delivered oxygen
and glucose by the mitochondria, hampering adenosine triphosphate (ATP) synthesis.
Cytochrome-c-oxidase concentration (oxCCO) is a chromophore involved in mitochondrial
oxygen delivery and utilization, which makes it also a possible noninvasive biomarker for
TBI monitoring.
The following subsections provide a concise description of the experimental results as
presented in the reviewed papers, their interpretation, as well as their drawn conclusions.
Summary of the Evidence on NIRS-Derived Oxygenation in TBI
The literature search returned 18 scientific publications that assessed NIRS-derived
oxygenation in TBI patients. Table 1 summarizes the main characteristics of the method-
ology and results presented in each paper. The documents were sorted chronologically
as is shown in the column of author and year of publication. Moreover, sample size (n)
is reported with the proportion of male and female (m:f) included in the studies. Table 1
also includes the type of NIRS devices used, the manufacturer, and the main technical
specifications. Additionally, all the comparisons between NIRS output and the control
measurements were extracted from the papers. In four cases, the comparison was be-
tween the outcome of the basal condition and after an intervention (i.e., hyperventilation,
MAP changes). Finally, the main conclusion of each author is shown in the last column of
the table.
Table 1. Summary of the evidence on NIRS-derived oxygenation in TBI.
Author, Year N (m:f) Device (Type) Output Control Conclusion
(Jöbsis, 1977) [21] 1 (1:0)
Inhouse NIRS,
non commercial
(CW; S-D 13.3 cm)
Photon count Paired measure:hyperventilation
Oxygen sufficiency can be
monitored noninvasively.
(Tateishi et al.,




(CW; S-D 4 cm)
HbO2 SjO2
Cerebral HbO2 magnitude and direction,
measured by NIRS, were similar to changes
in invasive measurements of SjvO2.
(Kirkpatrick et al.,








A close correlation between NIRS signals
and intracranial parameters strengthens the
belief that the observed chromophore
concentration changes are derived
primarily from cerebral tissues.
(Lewis et al.,
1996) [64] 10 (6:4)
INVOS 3100, Medtronic,
Minneapolis, MN, USA.
(SRS; S-D 3&4 cm)
rSO2 SjO2
Tissue oxygen saturation determined by
near-infrared spectroscopy does not reflect
significant changes in cerebral oxygenation
detected by the global measurement of
jugular venous bulb oximetry.
(Kampfl et al.,
1997) [65] 8 (5:3)
INVOS 3100A, Medtronic,
Minneapolis, MN, USA.
(SRS; S-D 3&4 cm)
rSO2 ICP
rSO2 values in patients with an ICP
> 25 mmHg were significantly lower than in
patients with an ICP < 25 mmHg after the
hyperoxygenation period.








rSO2 index represented a summation of
differential weighting of SaO2 (20%), SjvO2
(75%), and extracranial O2 saturation (5%).
(Ter Minassian
et al., 1999) [67] 9 (NR)
INVOS 3100, Medtronic,
MN, USA.
(SRS; S-D 3&4 cm)
rSO2 SjO2
rSO2 assessed by NIRS does not adequately
reflect changes in SjvO2 in patients with a
severe head injury.
(Cheng et al.,




(CW; S-D 3.5 cm)
HbO2
oscillations NR
The presence of oscillations at 0.013–0.033,
0.11, and 0.19–0.28 Hz are compatible with
B-waves, vasomotion, and respiratory
cycles, respectively.
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Table 1. Cont.
Author, Year N (m:f) Device (Type) Output Control Conclusion
(Brawanski et al.,
2002) [69] 12 (11:1)
INVOS 3100, Medtronic,
Minneapolis, MN, USA.
(SRS; S-D 3&4 cm)
rSO2 PbtO2
rSO2 and PbtO2 contain similar information
from a mathematical point of view.
(McLeod et al.,




(SRS; S-D 4 cm)
TOI SjO2 and PbtO2
Altering the fraction of inspired oxygen
changes significantly each variable
measured of cerebral oxygenation.
Each variable represents a different
physiologic process.
(Kim et al., 2010)
[71] 8 (5:3)
Inhouse, noncommercial
(CW; S-D 2.5 cm) DCS and HbO2 XeCT
Significant moderate correlations between
DCS measurements of relative CBF and
NIRS measurements of delta HbO2
were demonstrated.
(Leal-Noval





PbrO2 and rSO2 were directly and
significantly related. However,
the diagnostic accuracy of rSO2 was limited,
therefore, that measurement by NIRS
should not be considered to be an
acceptable substitute for PbrO2.
(Tachtsidis et al.,
2011) [73] 6 (5:1)
Broadband NIRS,
noncommercial
(CW; S-D 3.5 cm)
oxCCO Paired measure:hypercapnia
Despite the increase in total HbO2 in all
patients, only four of the six patients
showed an increase in the oxidation states.
(Ghosh et al.,
2013) [74] 10 (3:7)
Inhouse, noncommercial




Optical measurement of chromophore
concentration in the injured brain is not
confounded by changes in optical scattering
or pathlength.
(Rosenthal et al.,
2014) [75] 18 (13:5)
CerOx 3110, Ornim






The correlation between UT-NIRS
measurements and SjvO2 indicate that the
CerOx may be able to provide a
noninvasive estimation of cerebral
oxygenation status in brain-injured patients.
However, rSO2 was not correlated
with PbtO2.






rSO2 values were determined as a strong
discriminator and predictor of hospital
mortality. When rSO2 < 68.0% in the left
hemisphere HR = 17.7.
(Durnev et al.,







NIRS signals of cerebral hypoxygenation
reacted first to MAP changes.
(Davies et al.,
2019) [78] 16 (9:3)
Oxiplex TS, ISS, Il, USA.
(PMS; NR) rSO2 PbtO2
A clear predictive relationship between
NIRS and invasively measured PbtO2 has
been established. However, FD enhances
NIRS device tested did not demonstrate
sufficient reproducibility in its ability to
predict changes in PbtO2 to replace the
current invasive gold standard.
Abbreviations: regional tissue oxygen saturation (rSO2), hemoglobin concentration (HbO2), jugular bulb venous saturation (SjO2), cerebral
perfusion pressure (CPP), intracranial pressure (ICP), cerebral blood flow (CBF), arterial oxygenation (SaO2), brain tissue oxygen tension
(PbtO2), xenon-enhanced computed tomography (XeCT), mean arterial pressure (MAP), hazard ratio (HR), frequency domain (FD),
near-infrared spectroscopy (NIRS), cytochrome-c-oxidase concentration (oxCCO), continuous wave modified Beer–Lamber law (CW),
spatially resolved spectroscopy (SRS), phase modulated spectroscopy (PMS), ultrasound-tagged near-infrared spectroscopy (UT-NIRS),
source detector distance (S-D), not reported (NR).
Sample Size and Patient Demographics
This review identified 17 publications spanning between 1995 and 2019 where NIRS
was used for oxygenation monitoring in TBI patients. The only publication that was
included in this review without meeting the inclusion criteria was Jöbsis publication.
This exception was made due to Jöbsis’s pioneering work being the first approach to
NIRS application in vivo, which demonstrated that oxygen sufficiency can be monitored
noninvasively using NIR light [21]. Moreover, Figure 8 shows that 75% of the studies had a
sample size smaller than 15 patients, which is a limitation in the results of almost all these
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publications. Likewise, it was not surprising that in 15 of the 16 papers that included the sex
ratio, the number of men was significantly higher than the number of women. Literature
has always reported a proportion of males greater than that of females [1], where men have
more than double the risk of TBI than women [2]. Finally, the mean or midrange age (grey
line) was stated in 16/18 papers, therefore, a weighted average of 43.4 years was calculated
(yellow line). Interestingly, all studies included mostly middle-aged people, who are at risk
of suffering severe TBI but can also be rapidly stabilized in intensive care.
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Distribution of NIRS Techniques 
Figure 9 shows the distribution of NIRS techniques used for oxygenation monitoring 
in TBI patients. As it was expected, the most-used technique was continuous wave (CW) 
NIRS, analyzed by either the modified Beer–Lambert law or spatially resolved spectros-
copy (SRS) algorithms. The latter considered source–detector (S-D) distances between 2.5 
and 6 cm in reflectance mode. Jöbsis is the only author who utilized transmission mode 
with an S-D distance of 13.3 cm. Time-resolved spectroscopy has not been reported in TBI 
monitoring yet, as nowadays this technique is mainly used in research laboratories [39]. 
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Figure 9 sho s the distribution of NIRS techniques used for oxygenation monitor-
ing in TBI patients. As it was expected, the most-used technique was continuous wave
(CW) NIRS, analyzed by either the modified Beer–Lambert law or spatially resolved spec-
troscopy (SRS) algorithms. The latter considered source–detector (S-D) distances between
2.5 and 6 cm in reflectance mode. Jöbsis is the only author who utilized transmission mode
with an S-D distance of 13.3 cm. Time-resolved spectroscopy has not been reported in TBI
monitoring yet, as nowadays this technique is mainly used in research laboratories [39].
Davies et al. reported the only paper included in this review, which compared phase modu-
lated spectroscopy with the invasive measurement of brain tissue oxygenation tension [78].
Finally, Rosenthal et al. used a novel technique called ultrasound-tagged near-infrared
spectroscopy (UT-NIRS), which is a hybrid technology that induces an artificial modulation
in the detected light intensity by applying ultrasound waves. In this manner, only light
from a specific volume of brain tissue is selected for analysis [75].
Appropriate Clinical Comparable Parameters
Different comparisons have been done in the last few years to assess the capability
of NIRS in oxygenation monitoring. Primarily, five papers have compared NIRS-derived
measurements before and after an intervention. Jöbsis compared the amount of photons
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detected by the photodetector at different stages of hyperventilation [21], while Tachtsidis
et al. and Ghosh et al. assessed the variations in oxidized–reduced cytochrome c oxidase
(oxCCO) concentration before and after changing PaCO2 and FiO2, respectively [73,74].
Likewise, Durnev et al. correlated rSO2 with changes in MAP, while Cheng et al. assessed
the signal oscillations present in hemoglobin concentration [68,77]. The distribution of
these paired measurements is shown in light blue in Figure 10.
Figure 9. Distribution of NIRS techniques used for oxygenation monitoring in TBI patients.
Where continuous wave modified Beer–Lamber law (CW MBL), spatially resolved spectroscopy (SRS),
phase modulated spectroscopy (PMS), and ultrasound-tagged near-infrared spectroscopy (UT-NIRS).
Figure 10. Comparisons found in the evidence on NIRS-derived oxygenation in TBI.
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On the other hand, independent comparisons were found between the NIRS-dependent
outcome and a group of physiological variables. In these evaluations, each variable of the
control group was not compared with NIRS outcome directly. In Kirkpatrick’s paper, ICP,
CPP, and relative CBF changes were not compared individually with hemoglobin concen-
tration, yet it was reported that NIRS only registered obvious changes when the control
group varied [63]. Similarly, McLeod et al. did not assess the correlation between TOI and
invasive measurements, however, altering the fraction of inspired oxygen, each cerebral
oxygenation variable changed significantly [70]. Furthermore, Kerr et al. used a regression
model to define rSO2 as a function of the control variables SaO2, SjvO2, and extracranial
SO2. The coefficients in this model were the weights of each control variable adjusted by
all the parameters included in the regression [66].
Finally, independent comparisons were reported between NIRS measurements and ref-
erence variables such as SjvO2, PbtO2, ICP, or XeCT. The latter was only used by Kim et al.
to examine the correlations between changes in NIRS parameters and changes in CBF,
determined by XeCT [71]. Another specific comparison that was reported only in one
paper was done by Kampfl et al., who evaluated rSO2 values in patients with high and low
ICP (threshold = 25 mmHg) after hyperoxygenation [65]. Conversely, invasive oxygenation
parameters SjvO2 and PbtO2 were widely used as reference variables or gold standard
measurements. Both variables’ distributions are shown in Figure 10 in green and red,
respectively. Jugular venous oxygen saturation monitoring using a fiberoptic catheter is the
method that is currently accepted as a technique for continuous measurement of cerebral
oxygenation [56,62–64,67]. However, it entails technical difficulties, including a relatively
small amount of time for collecting good quality data and the need for frequent recalibra-
tions [75]. Also, as NIRS measurements represent the average value of arterial, capillary,
and venous blood, there can be a difference in the time course of oxy- and deoxyhemoglobin
from that in SjO2 [62]. On the other hand, PbtO2 is not yet an accepted gold standard
technique for cerebral monitoring, although some studies used it as such [56,69,72,79].
Simultaneous comparison of PbtO2 and rSO2 is problematic, as each monitor utilizes a
distinct physical principle and measures a distinct physiological parameter [72].
3.4.2. Autoregulation
Physiology of Autoregulation in TBI
Autoregulation is the capacity of cerebral circulation to maintain a continuous and
independent CBF and adequate oxygen supply despite changes in blood pressure, cerebral
perfusion pressure, hematocrit, blood viscosity, and partial pressure of arterial oxygen
and carbon dioxide [80,81]. Multiple physiological processes are involved in cerebral
autoregulation, where the myogenic mechanism relies on the cerebrovascular reactivity
(CVR), which can provoke either vasodilatation or constriction. A decrease of mean arterial
pressure (MAP) or cerebral perfusion pressure (CPP) causes cerebral vasodilatation, while
an increase of MAP or CPP leads to vasoconstriction. [82]. However, CVR is not exclusively
associated to variations in pressure; changes in other physiological processes such as CO2
or O2 reactivity, mediated by activation of nitric oxide, H+ ions, and other metabolites in the
arterial endothelium, can also lead to a rapid cerebral vasomotor response which regulates
CBF [82,83]. The latter is known as the metabolic mechanism, and it may be initiated by
hypoxia, dehydration, or hypercapnia [80]. Finally, the neurogenic mechanism focuses
on neurotransmitter-mediated changes in vascular tone, originated by fluctuations in the
sympathetic and parasympathetic system [81]. For instance, the trigeminal-cerebrovascular
system plays a central role in counteracting vasoconstriction through the production of
calcitonin gene-related peptide (CGRP), a potent vasodilator [81,84].
When autoregulation is intact, suitable coupling is observed between a small rise
in CBF and metabolism [80]. In most cases, autoregulation pressure lies in the range of
50–150 mmHg [85]. In chronic arterial hypertension, autoregulation limits are displaced
to higher levels, shifting the curve to the right as high as 40 mmHg [85]. Another charac-
teristic of this protector mechanism is its temporal response, which occurs within two to
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ten seconds after a sudden change in MAP/CPP [83]. Figure 11 represents the behavior of
relevant hemodynamic variables in the function of CBF. It depicts that out of the autoregu-
latory plateau, CBF becomes pressure-dependent, resulting in too much or too little blood
perfusion to the brain [80].
Figure 11. Cerebral autoregulation, where cerebral blood flow is maintained constant over a range of
MAP/CPP. Out of the autoregulatory plateau, CBF becomes pressure-dependent and intracranial
pressure dangerously rises (modified from [80,83,85,86]). Hypotension with disrupted cerebral
autoregulation rapidly leads to cerebral ischemia, while hypertension above the autoregulatory
threshold increases the risk of hyperemia.
After brain trauma, cerebral hemodynamic variables change as a response to secondary
injuries like hemorrhages, edema, or BBB disruption. In accordance, blood pressure
might drop by substantial blood loss due to extracranial injuries. Significant hemorrhage
decreases stroke volume and cardiac output, causing the body to compensate through
systemic vasoconstriction [87,88]. Thus, hypotension leads to the vessels’ passive collapse,
which reduces CBF, CPP, and increases oxygen extraction from hemoglobin, but for CBF
below 20 mL/100 g/min the brain becomes ischemic. Likewise, secondary injuries can also
initiate a “vicious cycle” (a term widely described in the literature in this field [12,66,89,90]),
where increased intracranial volume raises intracranial hypertension, which in turn leads to
arterial hypertension as a compensatory response to maintain CPP (cushing response) [91].
However, under autoregulatory failure conditions, the latter response increases CBF, which
exacerbates secondary brain injury (Figure 11) [91].
Summary of the Evidence on NIRS-derived Autoregulation in TBI
The literature search returned nine scientific publications that assessed NIRS derived
autoregulation in TBI patients. Table 2 summarizes the relevant data extracted from each
document. The papers were sorted chronologically by publication year, as is presented in
the first column of the table along with the author. Moreover, sample size (n) is reported
with the proportion of male and female (m:f) included in the studies. Column three of
Table 2 includes the NIRS devices used, the manufacturer, and some technical specifications
in brackets. Furthermore, NIRS outputs and control measurements are shown in columns
four and five. Only in one case the comparison was between TBI patients and healthy
control volunteers. Finally, the main conclusion of each paper is shown in the last column
of the table.
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Table 2. Summary of the evidence on NIRS-derived autoregulation in TBI.
Author, Year N (m:f) Device (Type) Output Control Conclusion
(Adelson et al.,












High ICP and decreased CPP
correlated with increased THb
and HbO2 indicating raised CBV










rSO2 CPP, MAP, ICP
Cerebral oximetry correlated
significantly with CPP. As such,
it could be an adjunct to CPP
management.
(Zweifel et al.,






THx showed a significant
correlation with the validated
volume reactivity index PRx.
(Shafer et al.,





The relationship between either
the left or right NIRS values and
Xe/CT scan was not significant.
(Diedler et al.,






The agreement between PRx and
THx is a function of the power of
slow oscillations in the
input signals.
(Taussky et al.,




(CW; S-D 4.5 cm)
rSO2 CBF
CT perfusion CBF has a
significant linear correlation with
NIRS derived rSO2.





(SRS; S-D 2.5 cm)
CBF, ∆HbO2,
∆Hb and ∆THb
in 10 TBI patients
CBF, ∆HbO2,
∆Hb and THb in
10 healthy
controls
HbO2, Hb, and THb
concentration increased
significantly in the brain-injured
cohort with head-of-bed lowering.
Accordingly, DCS/NIRS hybrid








(SRS; S-D 4 cm)
THx, TOx PRx, Mx
Significant agreement among PRx
and THx, and between Mx and
TOx. However, the strength of the
interrelationship between ICP or
TCD and NIRS signals, THI or











gives a similar measurement of
cerebrovascular autoregulation
to iTOx.
Abbreviations: regional tissue oxygen saturation (rSO2), oxyhemoglobin concentration (HbO2), total hemoglobin concentration (THb), de-
oxyhemoglobin concentration (Hb), concentration change (∆), cerebral perfusion pressure (CPP), intracranial pressure (ICP), cerebral blood
flow (CBF), partial pressures of arterial carbon dioxide (PaCO2), xenon-enhanced computed tomography (XeCT), mean arterial pressure
(MAP), pressure reactivity index (PRx), total hemoglobin reactivity index (THx), tissue oxygen reactivity index (TOx), mean velocity index
(Mx), noninvasive tissue oxygen reactivity index (nTOx), invasive tissue oxygen reactivity index (iTOx), near-infrared spectroscopy (NIRS),
continuous wave modified Beer–Lambert law (CW), spatially resolved spectroscopy (SRS), source detector distance (S-D), not reported (NR).
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Sample Size and Patient Demographics
This review identified nine documents spanning between 1998 and 2015 where NIRS
was used for autoregulation monitoring in TBI patients. Figure 12 shows that only 25% of
the studies had a sample size larger than 27 patients, which is a limitation in the results
of almost all these publications. As aforementioned, men being at more than double the
risk of TBI than women [2], which agrees with the weighted average of the sex ratios
(m/f = 1.9). Finally, the mean or midrange age is presented in Figure 12 with a grey colour
line. One outlier in the age dataset can be noticed in the figure, and this is because this
study by Adelson et al. assessed TBI pediatric patients [86]. Therefore, age median is
46 years, and its interquartile range is between 34 and 56 years. Interestingly, all studies
included mostly middle-aged people, who are at risk of suffering severe TBI but can also
be rapidly stabilized in intensive care.
Figure 12. Demographics of the evidence on NIRS-derived autoregulation in TBI.
Distribution of NIRS Techniques
Figure 13 shows the distribution of NIRS techniques used for autoregulation mon-
itoring in TBI patients. Similarly, with the studies on oxygenation, the two most used
techniques for autoregulation assessment were continuous wave (CW) NIRS and spatially
resolved spectroscopy (SRS). Only three papers reported the source–detector (S-D) distance,
having values between 2.5 and 4.5 cm in reflectance mode [96–98]. The following three
brands were repetitively used in cerebral autoregulation papers: NIRO monitor from
Hamamatsu Photonics, INVOS system from Medtronic, and ForeSight Oximeter from
Casmed. However, the device model changed between authors. An inhouse hybrid system
was used in one of the included publications. Kim et al. presented a custom-built device
containing both diffuse correlation spectroscopy (DCS) and NIRS. DCS is a novel optical
technique for probing continuous changes in regional microvascular blood flow, while
NIRS was used for oxygenation parameters’ changes. Together, both techniques were
used to detect differences in cerebral hemodynamic responses of brain-injured patients to
posture change [97].
Appropriate Clinical Comparable Parameter
This section presents the different comparisons found in the literature to assess the
capability of NIRS in cerebral autoregulation monitoring. Comparisons are divided into
three types: (1) When NIRS-derived values are associated with physiological measurements,
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(2) when the clinical comparable parameter is an index, and (3) when TBI patients are
compared to healthy controls. The latest relates specifically to Kim’s paper, where two
cohorts were exposed to postural changes in order to identify whether a noninvasive in-
house system is able to detect CBF and hemoglobin changes (orange bar of Figure 14) [97].
Figure 13. Distribution of NIRS techniques used for autoregulation monitoring in TBI patients.
Figure 14. Comparisons found in the evidence on NIRS-derived autoregulation in TBI.
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In the first type are the comparisons made between NIRS variables, such as rSO2
or the concentration of different forms of hemoglobin, and physiological parameters
that are measured invasively or through tomographic images. As it was explained in
section “Physiology of Autoregulation in TBI”, the main variables involved in cerebral
autoregulation are CBF, CPP, MAP PaCO2, and ICP. In consequence, it is not surprising
that some authors aim to associate NIRS outcomes with these comparators [86,92,94,96].
In the second type, the comparisons are made between invasive and noninvasive
indexes. The most frequent observation is between pressure reactivity index (PRx) and
its noninvasive analogous total hemoglobin reactivity index (THx), as it is shown by the
fuchsia column in Figure 14 [93,98,100]. The pressure reactivity index is defined as the
moving correlation between MAP and ICP. When cerebrovascular reactivity is impaired,
intracranial volume (ICV) and ICP increase and decrease passively with MAP. Thus, a neg-
ative value for PRx, when ICP is inversely correlated with MAP, indicates normal reactivity,
and a positive value indicates impaired autoregulation [93,98]. Likewise, THx is calculated
as the moving correlation between the total hemoglobin index (THI = [HbO2] + [HHb])
and arterial blood pressure (ABP) [100].
Other comparisons between indexes were presented by Highton et al., who compared
the mean velocity index (Mx) with the tissue oxygen reactivity index (TOx). Interestingly,
both indexes are obtained using noninvasive techniques. For instance, Mx is derived from
transcranial Doppler-measured flow velocity and ABP, while TOx is the correlation between
NIRS-derived rSO2 and ABP. However, arterial blood pressure was measured invasively
using a 20-G radial cannula and a transducer placed at the level of the tragus [98]. Unlike
Highton’s study, Brinda et al. compared tissue oxygen reactivity indexes calculated as the
moving correlation coefficient between invasive ABP and rSO2 (iTOx), and the moving
correlation coefficient between noninvasive ABP and rSO2 (nTOx). The latter used a
Finometer photoplethysmograph (Finometer pro, Finapres Medical Systems, Netherlands)
for noninvasive arterial blood pressure monitoring [99].
4. Discussion
This review provides readers with a comprehensive summary of the technological
advancements in the field of NIRS for TBI monitoring. This analysis not only considered ap-
plications for TBI, but also investigated the use on NIRS in different patients’ demographics,
and described the most-used techniques and testing clinical comparable parameters.
Figure 15 summarizes the final conclusions from all reviewed papers on the suitability
of NIRS in monitoring oxygenation or autoregulation in TBI patients. Positive results are
defined as results where the comparison between NIRS and gold standard techniques
yielded high correlations or agreements, and negative results where such correlations were
not high. Figure 15 provides a general representation of the results presented by each
author, despite the heterogeneity in their hypothesis, methods, and outcomes. Additionally,
the chart depicts the risk of publication bias, where papers with positive results are more
likely to be published by indexed journals than those which rejected their hypothesis.
Regarding the application of NIRS in oxygenation monitoring, patients’ samples were
homogeneous amongst the evidence. However, there is still a lot of variation in NIRS
techniques and the reference measurements, which decreased the overall comparabil-
ity between the results. Technical parameters such as the algorithm used within NIRS,
wavelengths, and source–detector(s) separation differ between the commercially available
devices, making it difficult to draw robust comparisons between them. All the papers
which assessed paired oxygenation measurements reported positive results, which can
be considered as a significant change on NIRS signals before and after an intervention
(change on MAP, hyperoxia, hypercapnia, etc.). The interventions aim to disrupt normal
cerebral hemodynamics, so significant changes on NIRS outcomes strengthens the belief
that these are derived primarily from cerebral tissues and are highly correlated with brain
hemodynamic changes [21,68,73,74,77]. For example, papers related to oxCCO monitoring
reported that changes in concentration during normobaric hyperoxia represent an actual
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increase in mitochondrial aerobic metabolism [73,74]. On the other hand, in those cases
where NIRS-derived oxygenation parameters were compared with variables that are not
directly related to oxygenation, such as ICP, CBF or mortality, the authors also reported
positive findings [65,76,97]. For instance, rSO2 values in intracranial hypertensive patients
were significantly lower than in nonhypertensive patients [65]. Likewise, DCS cerebral
blood flow measurements had a moderate correlation with rSO2 [97]. Finally, rsO2 was
more accurate in discriminating and predicting hospital mortality than the traditional
clinical parameters [76].
Figure 15. Main conclusions of NIRS-derived monitoring in TBI. Each author concluded with a
positive (green) or negative (red) statements. In a few cases, authors reported positive results with
some limitations (yellow).
Conversely, studies that compared NIRS measurements with invasive oxygenation
monitoring techniques, such as SjO2 and PbtO2, had heterogeneous results. Hemoglobin
concentration measured by NIRS was correlated with SjO2 [62,63]. It was found that NIRS
detected visible changes in the chromophores levels when desaturation events occurred,
even with twice the sensitivity of SjO2, which might be explained by the fact that SjO2
sensitivity is affected by the venous blood that is drained from the sinuses to the jugular
veins [63]. Nonetheless, the agreement between regional tissue oxygen saturation and SjO2
was significant in only a few papers [64,66,67,70,75]. Similarly, rSO2 and PbtO2 contain
similar information from a mathematical point of view, but NIRS outcomes have not
demonstrated enough reproducibility in its ability to predict changes in PbtO2 in order to
replace this invasive measurement [69,72,78]. The technological heterogeneity between the
papers due to the use of CW-MBL or SRS may explain the contradictory nature of the data.
On the other hand, papers that used NIRS in autoregulation monitoring reported
generally positive conclusions despite the various methodological and technological lim-
itations of NIRS. For instance, some papers where NIRS-derived values were compared
with physiological measurements found significant correlations. Dunham et al. reported
an association between rSO2 levels above 75% and CPP ≥ 70 mmHg, while Taussky et al.
found a correlation between pairs of values of rSO2 and CBF [92,96]. However, Shafer et al.
reported no significant correlation between the above relationship and mentioned that an
expansion of the study to a greater number of patients may uncover such a relationship [94].
It is interesting that both authors Taussky et al. (n = 8) and Shafer et al. (n 22) compared
rSO2 measurements with CT-derived CBF and had such conflicting results. However, these
conflicting results might be due to methodological heterogeneities, including differences in
the NIRS devices used [94,96]. The last type 1 comparison (when NIRS-derived values are
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associated with physiological measurements) showed that during hyperventilation, ICP,
CPP, and PaCO2 correlated with total hemoglobin concentration measured by NIRS. As it is
known, during hyperventilation, decreased PaCO2 results in cerebral oxygen desaturation,
regardless of lCP levels. Then, NIRS positively predicted cerebral oxygen desaturation and
indicated increased total hemoglobin (relative CBV) [86]. These results are encouraging,
suggesting that NIRS can be used as a noninvasive monitoring method for the earlier
recognition and subsequent treatment of TBI secondary insults.
Likewise, the agreement between indexes was assessed successfully by several au-
thors [93,98–100]. Most of these papers used the NIRO systems from Hamamatsu Photonics
and reported significant a correlation between THx and PRx [93,98]. Diedler et al. sug-
gested that this agreement is a function of the power of slow oscillations in the input
signals [100]. Moreover, Highton also found significant agreement between TOx-NIRS
index and Mx-TCD index [98]. However, THx and TOx were not completely noninvasive
indexes, as they depended on the continuous invasive monitoring of MAP [93,98]. In order
to respond to this limitation, Bindra et al. calculated MAP using a Finometer photoplethys-
mography system and found similarities between partially invasive TOx and completely
noninvasive TOx [99]. Likewise, Kim et al. tested their hybrid DCS/NIRS instrumentation
in TBI patients and healthy controls [98]. The aforementioned paper suggested that future
studies in cerebral autoregulation should use multimodal monitoring combining NIRS
analysis of indexes, such as THx and TOx.
There is still a need for more research in NIRS-derived monitoring in TBI patients.
Current results are limited due to the small number of subjects evaluated. Studies with
representative sample size are needed in order to have inferable results in the TBI popula-
tion. Despite the positive results that NIRS showed in these research studies, there is still
more work to be done in comprehensively evaluating NIRS in order to be established as
a reliable and routine monitoring technique in TBI. Considering that brain oxygenation
and autoregulation are often measured in severe TBI patients, it is not surprising that
the studies included in this review investigated populations of severe TBI patients only.
However, most traumatic brain injuries are categorized as mild to moderate, and future
research on NIRS application would greatly benefit these patients who often do not receive
brain oxygenation or autoregulation monitoring [101].
Moreover, high metrological heterogeneity decreased the possibility of an overall con-
clusion, even between studies that utilized the same NIRS technique. Also, it is important
to define a valid clinical comparable parameter which reflects tissue brain oxygenation
and autoregulation, as the current invasive references utilize distinct physical principles
and measure distinct physiological parameters. For instance, SjO2 and PbtO2 techniques
provide complementary information reflecting different aspects of the cerebral oxygenation
cascade, but do not represent the regional tissue oxygen saturation. Likewise, a stan-
dardized clinical comparable parameter for autoregulation monitoring in neuro-critical
care centers is still missing, which may be due to the lack of dedicated autoregulation
monitors [81].
Additionally, the global outcome measures were not uniform across all studies, there-
fore, for future purposes of quantitative synthesis of the evidence, it is recommended
that the authors report Bland–Altman analysis. It is a simple and accurate way to as-
sess the agreement between two clinical variables and may help clinicians to compare a
new measurement method against a standard reference [102]. Table 3 summarizes some
strengths and limitations of this technology as reported in the papers included in this
review. The limitations presented below are highly related to the lack of standardization of
NIRS devices and some to patient-related factors.
Sensors 2021, 21, 1586 23 of 28
Table 3. Strengths and limitations of NIRS-derived oxygenation in TBI.
STRENGTHS OF NIRS
• Effective transmission of NIR light in biological tissue allows non-invasive monitoring of cerebral HbO2 and HHb,
blood volume, the redox state of cytochrome, and thereby cerebral oxygen sufficiency [21].
• Near-infrared spectroscopy findings demonstrated visible changes in HbO2 and Hb levels in approximately twice as many
desaturation events as those registered with SjO2 monitoring [63].
• The close correlation between NIRS signals and those derived from known intracranial parameters strength-ens the belief that
the observed chromophore concentration changes are derived primarily from cerebral tissues [63].
• NIRS may be a valuable tool in the detection of impaired microcirculation and/or local brain tissue oxygena-tion in patients
with increased intracerebral pressure, which may not be detectable employing monitoring of CPP, blood gas analysis,
and TCD velocities [65].
• The rS02 index provides an easy, noninvasive method to measure decrements in oxygen delivery or utilization of O2 within
the brain [66].
• NIRS is able to provide a clinically accessible, continuous, and noninvasive measure of cerebral hemodynamic and therefore
has considerable potential as a noninvasive monitor of cerebral autoregulation [98].
LIMITATIONS OF NIRS
• Penetration of light is limited to several centimetres in-depth, and the precise sampling volume and site of measurement are
not fully clear [62].
• Hemoglobin in vessels of superficial structures may add extracerebral signals, and hence adding interference to CW-NIRS
measurements [62].
• Bulky, sensitive to variations in room temperature, and exquisitely sensitive to outside light [63].
• The signals also display drift and are sensitive to movement artifact [63].
• Alterations in cerebral blood flow and metabolism following severe head injury are heterogeneous, and re-gional differences
measured by NIRS may not be reflected by a global measurement such as jugular venous bulb oximetry [64].
• The rS02 index reflects a regional measure, while the jugular venous gas analysis is global [66].
• The pathlength factor and the depth concerning head swelling following trauma make the site of measure-ment and the
volume sample ambiguous [66].
• The cerebral signal could be contaminated by a reflected signal from extracerebral structures (e.g., bone, mus-cle) with
unpredictable partition and O2 saturation characteristics [67].
• The clinical use of NIRS remains limited by potential sources of error that include contamination of the signal by the
extracerebral circulation (principally the scalp), extraneous light, and the presence of extravascular blood [70].
• Hematomas may prevent sufficient photon transmission through the cortex due to excessive absorption by the concentrated
blood [71].
• Edema directly beneath the optical probes may also prevent signal detection when light absorption is high [71].
• In NIRS studies, many severe TBI patients are excluded from data analysis because of intra- and extracranial problems [72].
• Other patient-related factors affecting the NIRS-derived values include patient agitation, skin conditions (burn, infection,
or scar), brain malformation, polycythemia, and subcutaneous fat [54].
The main strength of this review is that it presents a synthesis of NIRS applications
specifically for TBI patient monitoring. Additional challenges are related to measuring light
tissue interaction changes after TBI, due to alterations in the pathophysiological process and
damage in post-traumatic tissue. The latter makes it difficult to extrapolate NIRS results in
normal tissue to TBI patients with the possible presence of extracranial blood, subdural
air, hemorrhages, cerebral edema, and some other clinical scenarios. However, TBI as
an inclusion criterion restricted the number of studies included in this review. Likewise,
no attempts were made to identify or translate non-English language publications, and this
may have limited the inclusion of some relevant studies in this review. Also, publication
bias may have occurred, because only peer-reviewed literature was included, and public
health reports on NIRS monitoring in TBI may be available in the gray literature. However,
these criteria provided the added ability to focus on the results in the literature in line with
NIRS technological advancements in TBI monitoring.
5. Conclusions
This review is a synthesis of the characteristics and advantages of NIRS use in TBI and
the available evidence of the association between continuous NIRS-based measures and
commonly monitored neurophysiological parameters, such as oxygenation and cerebral
autoregulation. So far, evidence is primarily focused on monitoring adults with severe TBI,
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where CW and SRS are the most-used NIRS technologies. However, the methodological
approaches between studies remain heterogenous. The above might be due to the lack
of “dedicated autoregulation monitors”; likewise, the comparison of oxygenation gold
standards with NIRS-derived paraments is problematic, as each monitor utilizes a distinct
physical principle and measures a distinct physiological parameter. As oxygenation and
autoregulation seem to play a crucial role in patient treatment and outcome, the potential
use of NIRS in combination with multimodal monitoring is in the best interest of both TBI
patients and clinicians.
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